Literature DB >> 1913333

Muscarinic-receptor functioning in tracheas from normal and ovalbumin-sensitive guinea pigs.

Z J Yang1, D F Biggs.   

Abstract

Responses to bilateral vagal nerve stimulation, to field stimulation, and to exogenous methacholine and histamine were compared in tracheas isolated from (a) saline injected (i.p.) and saline-aerosol exposed guinea pigs (control), (b) ovalbumin-sensitized and saline-aerosol exposed (sensitized) guinea pigs, and (c) ovalbumin-sensitized and 2% ovalbumin-aerosol exposed (challenged) guinea pigs. Tracheal pressor responses (cmH2O; 1 cmH2O = 98.1 Pa) to nerve and field stimulation, and maximal responses to methacholine and histamine were significantly increased in animals from group c compared with groups a and b. Dose-response lines in response to the two agonists, expressed as percent maximal contraction, did not differ among the groups. The M1 antagonist pirenzepine (0.1-10 nM) selectively reduced responses to nerve stimulation in all three groups. The M2 antagonist gallamine potentiated responses to nerve or field stimulation in all three groups. We conclude that M1, M2, and M3 muscarinic receptor functioning is similar in control and ovalbumin-sensitized guinea pigs. Changes in post-receptor transduction mechanisms may mediate the increased responsiveness noted in animals from group c.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913333     DOI: 10.1139/y91-132

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  2 in total

1.  Dysfunction of muscarinic M2 receptors after the early allergic reaction: possible contribution to bronchial hyperresponsiveness in allergic guinea-pigs.

Authors:  R E ten Berge; R E Santing; J J Hamstra; A F Roffel; J Zaagsma
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

2.  The effect of allosteric antagonists in modulating muscarinic M2-receptor function in guinea-pig isolated trachea.

Authors:  D Spina; E Minshall; R G Goldie; C P Page
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.